| This page is intended for physicians and research scientists.
ISSUE: 1999/08/a
To view an abstract click on the title of the desired article. This will request Medline details from PubMed which is provided by the National Library of Medicine.
After viewing the abstract use your browser's [Back] button to return to this page.
- Contents
 References: Clinical / Prognostic Markers
- References: Basic Science / Neuroblastoma Research
- References: Neurobiology / Cell Physiology Research (neuroblastoma cell lines)
- Previous Issue of Recent Publications (1999/07/a)
- Next Issue of Recent Publications (1999/08/b)
- Back to NBL-PROF Home Page
Clinical / Prognostic Markers
Berdon WE, et al.
Neuroblastoma arising from the organ of zuckerkandl: an unusual site with a favorable biologic outcome.
Pediatr Radiol. 1999 Jul;29(7):497-502.
[Related articles] | Clapuyt P, et al.
Urachal neuroblastoma: first case report.
Pediatr Radiol. 1999;29(5):320-1.
[Related articles] | Gilbert J, et al.
Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies.
Am J Pathol. 1999 Jul;155(1):17-21.
[Related articles] | Graefe KH, et al.
Sympathomimetic effects of MIBG: comparison with tyramine.
J Nucl Med. 1999 Aug;40(8):1342-51.
[Related articles] | Hasan Z, et al.
Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
Eur J Pediatr Surg. 1999 Jun;9(3):138-41.
[Related articles]  MYCN Amplification
| Hirai M, et al.
1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment.
Genes Chromosomes Cancer. 1999 Jul;25(3):261-9.
[Related articles] | Poremba C, et al.
Telomerase activity distinguishes between neuroblastomas with good and poor prognosis.
Ann Oncol. 1999 Jun;10(6):715-21.
[Related articles] | Shimada H, et al.
The International Neuroblastoma Pathology Classification.
Cancer. 1999; 86(2):364-72.
[Related articles] | Shimada H, et al.
Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
Cancer. 1999 ;86(2):349-63.
[Related articles] | Tang XX, et al.
High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas.
Clin Cancer Res. 1999; 5(6):1491-6.
[Related articles] | Tohda C, et al.
Trigonelline-induced neurite outgrowth in human neuroblastoma SK-N-SH cells.
Biol Pharm Bull. 1999; 22(7):679-82.
[Related articles] | Trebo M, et al.
Brief report: Neuroblastoma in Down syndrome.
Med Pediatr Oncol. 1999 Aug;33(2):125.
[Related articles] |
Basic Science / Neuroblastoma Research
Akao Y, et al.
Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro.
FEBS Lett. 1999 Jul 16;455(1-2):59-62.
[Related articles] | Arcangeli A, et al.
Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF.
J Neurobiol. 1999 Aug;40(2):214-25.
[Related articles] | Casciano I, et al.
Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma.
Cell Death Differ. 1999 May;6(5):391-3.
[Related articles] | Chambery D, et al.
N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line.
Cancer Res. 1999 Jun 15;59(12):2898-902.
[Related articles] MYCN Amplification
| Fredriksson A, et al.
In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.
Life Sci. 1999;65(2):165-74.
[Related articles] | Hadano S, et al.
Genomic organization of the human caspase-9 gene on Chromosome 1p36. 1-p36.3.
Mamm Genome. 1999; 10(7):757-60.
[Related articles] Chromosome 1p
| Heuer JG, et al.
Neuroblastoma cells expressing mature IL-18, but not proIL-18, induce a strong and immediate antitumor immune response.
J Immunother. 1999; 22(4):324-35.
[Related articles] | Huang F, et al.
Differentiation induction subtraction hybridization (DISH): a strategy for cloning genes displaying differential expression during growth arrest and terminal differentiation.
Gene. 1999 Aug 5;236(1):125-131.
[Related articles] | Huang TS, et al.
A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells.
Pharm Res. 1999; 16(7):997-1002.
[Related articles] | Iitsuka Y, et al.
An Enhancer Element for Expression of the Ncx (Enx, Hox11L1) Gene in Neural Crest-derived Cells.
J Biol Chem. 1999 Aug 20;274(34):24401-24407.
[Related articles] | Meister B, et al.
Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma.
Eur J Cancer. 1999 ;35(3):445-9.
[Related articles] | Morikawa H, et al.
Opioid potentiation of N-type Ca2+ channel currents via pertussis-toxin-sensitive G proteins in NG108-15 cells.
Pflugers Arch. 1999 Aug;438(3):423-6.
[Related articles] | Sharma M, et al.
CDK-5-mediated neurofilament phosphorylation in SHSY5Y human neuroblastoma cells.
J Neurochem. 1999; 73(1):79-86.
[Related articles] | Shea TB, et al.
Neuronal intermediate filament protein alpha-internexin facilitates axonal neurite elongation in neuroblastoma cells.
Cell Motil Cytoskeleton. 1999;43(4):322-33.
[Related articles] | Takada N, et al.
Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas.
Cancer Res. 1999; 59(12):2810-4.
[Related articles] | Weber PJ, et al.
On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family.
Biol Chem. 1999; 380(6):653-60.
[Related articles] |
Neurobiology / Cell Physiology Research (neuroblastoma cell lines)
Previous Issue of Recent Publications (1999/07/a)
Next Issue of Recent Publications (1999/08/b)
Back to NBL-PROF Home Page
|
